论文部分内容阅读
背景介绍:美国心脏学会卒中委员会于2012年5月3日发布新版动脉瘤性SAH(aSAH)治疗指南。这是近10年全年来第三次修订。aSAH作为急诊常见急危重症,有较高的发病率和极高的致死致残率。近年来本病在诊断治疗方面有许多研究成就。掌握最新的诊疗技术,提高对aSAH的临床认识,了解“先兆出血的意义”。有利于提高治疗水平,降低aSAH的致死致残率。我们将分3部分进行介绍,本文概括介绍aSAH的流行病学状况,危险因素的预防及诊断措施进展。
Background: The American College of Cardiology Stroke Committee released a new version of the guidelines for the treatment of aneurysmal SAH (aSAH) on May 3, 2012. This is the third revision in the past 10 years. aSAH emergency as a common acute critically ill, have a higher morbidity and high mortality rate caused by death. In recent years, the disease diagnosis and treatment of many research achievements. Master the latest diagnostic techniques, improve clinical knowledge of aSAH and understand the meaning of “precursor bleeding”. Help to improve the level of treatment, reduce aSAH lethal morbidity. We will be divided into three parts, this article outlines the epidemiological status of aSAH, prevention and risk factors for the progress of diagnostic measures.